Oportun To Sell Credit Card Portfolio To Continental Finance
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Oportun (OPRT) said that it agreed to sell its credit card portfolio to Continental Finance.
Search
Newsletter
Stock Prices
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
Investing News
- Why Movies Cost So Much to Make
- Find the Right Bond at the Right Time
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1486127040-2d871407d82744269fa20ef56224f5ef.jpg "Where Can You Buy Netspend Cards?")
Where Can You Buy Netspend Cards?- Historically Famous Forex Traders
- Historically Famous Forex Traders
:max_bytes(150000):strip_icc():format(jpeg)/ABeginnersGuidetoCallBuying-e0433db389da44ebb6dee9682d72e612.jpg "A Beginner’s Guide to Call Buying")
A Beginner’s Guide to Call Buying- A Beginner’s Guide to Call Buying
- Investing in Chinese Stocks: A Guide
Debit Card vs. Credit Card: What’s the Difference?- Financial Assistance for Native Americans
Stock Market
- Stock Indexes are Moderately Higher as Chip Stocks Lead the Advance
- NVIDIA Stock Post 3-Month Split: Buy, Hold, or Sell?
- Stocks Rally on Chip Stock Strength and Chinese Stimulus
- Cathie Wood Says Software Is the Next Big AI Opportunity — 1 Spectacular Stock You’ll Regret Not Buying if She’s Right
- Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up
Stocks To Buy
- Stock Indexes are Moderately Higher as Chip Stocks Lead the Advance
- NVIDIA Stock Post 3-Month Split: Buy, Hold, or Sell?
- Stocks Rally on Chip Stock Strength and Chinese Stimulus
- Cathie Wood Says Software Is the Next Big AI Opportunity — 1 Spectacular Stock You’ll Regret Not Buying if She’s Right
- Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up